Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06895785 · ClinicalTrials.gov registry record · NA
Exalt Single-use Duodenoscope Vs Reusable Scope, a Randomized Controlled Trial
A NA study of Biliary Diseases and Pancreatic Duct Disorder, sponsored by Rush University Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT06895785 is a NA study of Biliary Diseases and Pancreatic Duct Disorder that is actively recruiting participants, run by Rush University Medical Center. The registered enrollment target is 100 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06895785, a NA study of Biliary Diseases and Pancreatic Duct Disorder, is actively recruiting participants, sponsored by Rush University Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
This randomized controlled trial (RCT) is designed to evaluate the new generation Exalt Model disposable duodenoscope compared to the reusable scope in terms of feasibility, ease of use, adverse events, number of crossover events, and infection rates.
Conditions Studied
Interventions
- DEVICE Exalt Model D
- DEVICE Reusable
Study Locations (1)
Illinois
- Rush University Medical Center - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2025-02-21 |
| Est. Completion | 2030-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06895785
The ClinicalTrials.gov registry entry for NCT06895785 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rush University Medical Center, which has 320 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Biliary Diseases appearing as the primary indexed condition, and to 2 interventions - of which Exalt Model D is the first listed.
NCT06895785 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT06895785 about?
NCT06895785 is a clinical study titled "Exalt Single-use Duodenoscope Vs Reusable Scope, a Randomized Controlled Trial". This randomized controlled trial (RCT) is designed to evaluate the new generation Exalt Model disposable duodenoscope compared to the reusable scope in terms of feasibility, ease of use, adverse events, number of crossover events, and infection rates.
What is the current status of trial NCT06895785?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2025-02-21. Estimated completion is 2030-05.
What conditions does trial NCT06895785 study?
This clinical trial studies the following conditions: Biliary Diseases, Pancreatic Duct Disorder.
What interventions are being tested in trial NCT06895785?
The interventions under investigation include: Exalt Model D (DEVICE), Reusable (DEVICE).
Who is sponsoring clinical trial NCT06895785?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06895785 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.